CAR-T Cells + Keytruda: New Immunotherapy for Pleural Mesothelioma?
Researchers at a top US cancer center are experimenting with a new approach to immunotherapy for pleural mesothelioma – with…
Study May Lead to Safer Immunotherapy for Mesothelioma
New research conducted in Europe and at Harvard University may open the door to safer immunotherapy for mesothelioma patients. Immunotherapy…
Early Data Show Promise for Galinpepimut-S and Opdivo in Mesothelioma Patients
A combination of the immunotherapy drugs galinpepimut-S and Opdivo may give mesothelioma patients a few extra months, according to newly-released…
Effectiveness of Keytruda: Dutch Study Offers Clues for Prediction
A new Dutch study offers some clues that might help doctors predict the effectiveness of Keytruda (pembrolizumab) in individual mesothelioma…
Treatment with Dendritic Cells Leads to Long-Term Mesothelioma Survival in Small Studies
Three small studies suggest that dendritic cells may offer a new, more promising way to fight malignant pleural mesothelioma. Dendritic…
Biomarkers | Diagnosis | Europe | Immune Systems | International | Research
Higher PD-L1 Protein May Predict Shorter Mesothelioma Survival
Mesothelioma patients with higher levels of the PD-L1 protein in their tumor cells have worse overall survival compared to those…
Different Mesothelioma Subtypes: Gene Study Could Lead to Targeted Treatments
A group of European pathologists say the different mesothelioma subtypes have significant differences in their pattern of gene expression. Exploiting…
Genetic Links to Mesothelioma Illustrated in New Interactive Model
An interactive model of protein interactions could reveal new genetic links to mesothelioma and even lead to new treatments. The…
Visualizing the Immune Profile of Mesothelioma Patients
Researchers at MD Anderson Cancer Center in Houston have come up with a better way to analyze the immune profile…
Europe | Immune Systems | International | New Drugs | Research | Treatments
ONCOS-102 Gets Fast Track Designation for Mesothelioma Treatment
An immunotherapy treatment called ONCOS-102 has received fast track designation from the FDA as a pleural mesothelioma therapy. Targovax is…